SEC Form 4 · accession 0001980648-26-000013
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chan Henry Lee
Officer — SVP, General Counsel
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 5:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F3 | Jun 8, 2026 | S | 711 | $270.2362 | D | 160 | D | |
| American Depositary SharesF1,F4 | Jun 8, 2026 | S | 160 | $271.2575 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 307,047 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.90 to $270.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.00 to $271.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.